GlobeNewswire·Nov 9, 2026, 9:00 AM ET

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance Health Group (Nasdaq: LFST) priced a secondary public offering of 45,000,000 common shares at $13.12 per share.
The shares are being sold by certain stockholders ("Selling Stockholders"), who will receive all proceeds from the offering.
LifeStance is not selling any shares in this offering & will not receive any proceeds.
LifeStance agreed to purchase 2,000,000 shares from the underwriters to be sold by the Selling Stockholders under a Repurchase agreement.
The Repurchase is conditioned on the offering's completion but is not a condition for the offering to close.
Barclays & J.P. Morgan are acting as underwriters for the transaction.
The offering & Repurchase are expected to settle around November 12, 2026.
The offering was made pursuant to an automatic shelf registration statement filed with the SEC on May 21, 2024.
LifeStance employs over 8,800 clinicians & operates in 35 states across more than 550 centers.
The press release includes forward-looking statements regarding the offering terms & business expectations.